Table 1.
Data on PrEP access from online surveys in Germany, 2017–2020, and estimation of absolute number of PrEP users
| EMIS-2017 | PrApp round 1 (07/2018) | PrApp round 2 (05/2019) | PrApp round 31, PrEP prescription data 12/2019 |
PrApp round 31, PrEP prescription data 06/2020 |
Scenario 2** 06/2020 PrEP prescription data 2020, presumed self-pay 20%, informal sources 5% |
|
|---|---|---|---|---|---|---|
| a) Survey data | % | % | % | % | % | % |
| Medical prescription in Germany | 56 | 81 | 83 | 94 | 94 | 95 |
| Blister pack PrEP | 56 | 54 | 58 | n.a. | n.a. | n.a. |
| Other sources (informal, self-pay non-blister-PrEP generics, trials) | 44 | 46 | 42 | n.a. | n.a. | n.a. |
| Prescription on statutory health insurance | n.a. | n.a. | 5 | 80 | 80 | 75 |
| Prescription self-pay (blister pack PrEP + other generics) | 56 | 81 | 82 | 14 | 14 | 20 |
| Informal | 44 | 19 | 13 | 6 | 6 | 5 |
| Proportion PrEP on demand | 29 | 29 | 30 | 19 | 19 | 40 |
| Proportion of PrEP users participating in survey | 37% | 28% | 34% | 6% | n.a. | |
| Scenario 1 (based on survey result)* | Scenario 2 ** | |||||
| b) estimation of absolute number of PrEP users | N | N | N | N | N | N |
| Number of blister pack PrEP/ private self-pay prescriptions | 513 | 3125 | 4022 | 1796 | 1904 | 2877 |
| Number of monthly health insurance prescriptions | 10,176 | 10788 | 10788 | |||
| Number of PrEP users on prescribed PrEP | 660 | 4018 | 5171 | 13,814 | 14,644 | 20,497 |
| Number of PrEP users on informal sources/other (non blister pack) self-pay generics | 518 | 3423 | 3745 | 882 | 935 | 1079 |
| Estimated total number of PrEP users | 1178 | 7440 | 8916 | 14,695 | 15,579 | 21,576 |
n.a. = not applicable.
1data from PrApp-Survey round 3 was collected in 03/2020
*assumptions scenario 1: 33% (20%) on-demand/intermittent users, three on-demand/intermittent users supported by one full monthly dose
**assumptions scenario 2: 40% on-demand/intermittent users, six on-demand/intermittent users supported by one full monthly dose